Business Economy


Aurobindo pharma Q2FY25 reports consolidated net profit of Rs 817 crore

Hyderabad, Nov 9 (UNI) Aurobindo Pharma, an integrated global pharmaceutical company, reported a consolidated net profit of Rs 817 crore for the quarter that ended September 30, 2024, up 8.6 percent from Rs 752 crore a year ago.
Consolidated Revenue from Operations during the quarter increased by 8 percent Y-o-Y to Rs 7,796 crore with growth across the businesses, Hyderabad-based pharma company said in a release here on Saturday.
In Q2FY24, the company’s revenues stood at Rs 7,219 crore
Operational Performance (Consolidated), the company said that its revenues from US formulations (excluding Puerto Rico) increased by 4.3 percent YoY to Rs 3,530 crore (USD 421 million) while from Europe formulations increased by 19 percent YoY to Rs 2,105 crore (EUR 229 million) and growth Markets revenue up by 44 percent YoY to Rs 812 crores (USD 97 million).
The Pharma Company spent Rs 410 crore, 5.3 percent on revenues on Research & Development (R&D including depreciation).
Commenting on the Company’s performance, Aurobindo Vice-Chairman and Managing Director K. Nithyananda Reddy, said: "We are pleased with the continued growth in revenues across our key business areas this quarter, reflecting the resilience of our diversified portfolio. While profitability saw a slight dip, primarily due to the transient nature of certain business activities, our underlying performance remains strong. With a solid foundation and ongoing operational improvements, we are confident of maintaining our growth trajectory and achieving our strategic objectives for the year."
The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients globally in over 150 countries.
The company has 29 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA.
UNI KNR BD
More News

Cottonseed, oil & meal conclave 2025 to be held on August 2, 3

15 Jul 2025 | 11:47 PM

Vijayawada, July 15 (UNI) The Solvent Extractors’ Association of India (SEA) & All India Cottonseed Crushers’ Association (AICOSCA) will organise the sixth SEA–AICOSCA Cottonseed, Oil & Meal Conclave 2025 in here on August two and three.

see more..

BIMSTEC Ports conclave on 2nd day witnesses intensive deliberations on regional trade, cruise tourism & maritime collaboration

15 Jul 2025 | 11:36 PM

Visakhapatnam, July 15 (UNI) The final day of the two-day second BIMSTEC Ports Conclave, here today, featured a series of high-level panel discussions centred on enhancing regional maritime cooperation, port efficiency, cruise tourism and human resource development across the Bay of Bengal region.

see more..

India Process Expo & Conference and Eco Sustain Expo, in Hyderabad from from August 22–24

15 Jul 2025 | 11:18 PM

Hyderabad, July 15 (UNI) Hitex, Hyderabad’s premier exhibition centre, hosted two insightful panel discussions on Bio-Energy and Industrial Waste Management here today as a curtain-raiser to two major industrial expos scheduled next month.

see more..

Zurich Kotak General Insurance unveils EV Protect; now live for Tesla, EVs

15 Jul 2025 | 11:08 PM

Mumbai, July 15 (UNI) Zurich Kotak General Insurance has announced the launch of EV Protect, a comprehensive add-on covers within its car insurance product, Car Secure, for Indian electric vehicles (EVs), which covers Tesla among other EVs.

see more..

Indian auto sector shows resilience amid Q1 headwinds

15 Jul 2025 | 11:05 PM

Mumbai, July 15 (UNI) India's automotive sector delivered a mixed performance during the first quarter of FY2025-26, with most segments registering marginal declines despite record achievements in select categories, according to Society of Indian Automobile Manufacturers (SIAM) data released here today.

see more..